BPC-157 and TB-500 are synthetic peptides widely studied for their potential roles in tissue regeneration, wound healing, and cellular repair. Both peptides are being researched in fields such as angiogenesis, musculoskeletal recovery, and inflammation modulation. Their combination has attracted interest in scientific studies due to their complementary mechanisms of action, particularly in models of soft tissue, joint, and neurovascular repair.
Nasal delivery is a popular research method for peptides due to its potential to:
Studies suggest that intranasal administration may support peptide transport into circulation and the central nervous system (CNS), making it a viable route for investigating neurological, vascular, and tissue repair properties.
BPC-157, a synthetic pentadecapeptide, is derived from Body Protection Compound (BPC), originally found in gastric juices. It has been studied for its potential to:
TB-500, a synthetic version of Thymosin Beta-4 (Tβ4), is a naturally occurring peptide in many tissues and cells. It has been studied for its potential to:
Studies suggest that BPC-157 and TB-500 may have complementary effects when studied together in areas such as:
BPC-157 & TB-500 are intended for research purposes only. They are not for human consumption, medical use, or diagnostic applications. All information provided is for scientific and educational research.
LP10 FOR 10% OFF YOUR ORDER